keyword
https://read.qxmd.com/read/38669816/uplc-triple-tof-ms-based-serum-metabonomic-revealed-the-alleviating-effect-of-qingyan-formula-on-perimenopausal-syndrome-rats
#41
JOURNAL ARTICLE
Zhao Zou, JiaShan Li, Yuan Li, YiBo Yang, PanYu Xu, HanQian Du, Li Guo, ZeHui Li, Na Lin, Ying Xu
The study aimed to investigate the relieving effect of QingYan Formula (QYF) in treating perimenopausal syndrome. A combination of metabonomic analysis and in vitro pharmacodynamic experiments was employed to achieve this objective.Over a period of 12 weeks, ovariectomized (OVX) rats were orally administered QYF's 70 % ethanol extract or estradiol valerate (EV). The results demonstrate that QYF restored the estrous cycle of ovariectomized rats and exhibited significant estrogenic activity, as indicated by reversal of uterine and vagina atrophy, improvement of serum estradiol level and decrease of serum luteinizing hormone(LH) level...
April 22, 2024: Journal of Pharmaceutical and Biomedical Analysis
https://read.qxmd.com/read/38668105/the-conventional-and-breakthrough-tool-for-the-study-of-l-glutamate-transporters
#42
REVIEW
Kanako Takahashi, Kaoru Sato
In our recent report, we clarified the direct interaction between the excitatory amino acid transporter (EAAT) 1/2 and polyunsaturated fatty acids (PUFAs) by applying electrophysiological and molecular biological techniques to Xenopus oocytes. Xenopus oocytes have a long history of use in the scientific field, but they are still attractive experimental systems for neuropharmacological studies. We will therefore summarize the pharmacological significance, advantages (especially in the study of EAAT2), and experimental techniques that can be applied to Xenopus oocytes; our new findings concerning L-glutamate (L-Glu) transporters and PUFAs; and the significant outcomes of our data...
March 27, 2024: Membranes
https://read.qxmd.com/read/38667048/comparative-pharmacokinetics-of-gentamicin-c-1-c-1a-and-c-2-in-healthy-and-infected-piglets
#43
JOURNAL ARTICLE
Eun-Young Kim, Tae-Won Kim, Elias Gebru Awji, Eon-Bee Lee, Seung-Chun Park
Gentamicin, an aminoglycoside antibiotic, is a mixture of therapeutically active C1 , C1a , C2 and other minor components. Despite its decades-long use in pigs and other species, its intramuscular (IM) pharmacokinetics/pharmacodynamics (PKs/PDs) are unknown in piglets. Furthermore, the PKs of many drugs differ between healthy and sick animals. Therefore, we investigated the PKs of gentamicin after a single IM dose (10 mg/kg) in healthy piglets and piglets that were intranasally co-infected with Actinobacillus pleuropneumoniae and Pasteurella multocida (PM)...
April 18, 2024: Antibiotics
https://read.qxmd.com/read/38667031/pharmacokinetics-of-enrofloxacin-in-plasma-urine-and-feces-of-donkey-equus-asinus-after-a-single-intragastric-administration
#44
JOURNAL ARTICLE
Bowen Yang, Shijie Liu, Jie Cheng, Honglei Qu, Yanxin Guo, Chuanliang Ji, Yantao Wang, Shancang Zhao, Shimeng Huang, Lihong Zhao, Qiugang Ma
Enrofloxacin is a broad-spectrum antimicrobial agent, but the study of its pharmacokinetics/pharmacodynamics (PKs/PDs) in donkeys is rarely reported. The present study aimed to investigate the pharmacokinetics of enrofloxacin administered intragastrically, and to study the pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in plasma, urine, and feces, and the PK/PD parameters were investigated to provide a rationale for enrofloxacin treatment in donkeys. A total of five healthy donkeys were selected for intragastric administration of 7...
April 12, 2024: Antibiotics
https://read.qxmd.com/read/38667020/comparative-efficacy-of-continuous-ceftazidime-infusion-vs-intermittent-bolus-against-in-vitro-ceftazidime-susceptible-and-resistant-pseudomonas-aeruginosa-biofilm
#45
JOURNAL ARTICLE
Cristina El Haj, Eugènia Agustí, Eva Benavent, Laura Soldevila-Boixader, Raül Rigo-Bonnin, Fe Tubau, Benjamín Torrejón, Jaime Esteban, Oscar Murillo
Background : As the anti-biofilm pharmacokinetic/pharmacodynamic (PK/PD) properties of antibiotics are not well-defined, we have evaluated the PK/PD indices for different regimens of ceftazidime (CAZ; with/without colistin) against Pseudomonas aeruginosa biofilm. Methods : We have used the Center for Disease Control and Prevention Biofilm Reactor with two susceptible (PAO1 and HUB-PAS) and one resistant (HUB-XDR) strains of P. aeruginosa . The regimens were CAZ monotherapies (mimicking a human dose of 2 g/8 h, CAZ-IB; 6 g/daily as continuous infusion at 50 mg/L, CAZ-CI50 ; and 9 g/daily at 70 mg/L, CAZ-CI70 ) and CAZ-colistin combinations...
April 9, 2024: Antibiotics
https://read.qxmd.com/read/38667012/revisiting-the-checkerboard-to-inform-development-of-%C3%AE-lactam-%C3%AE-lactamase-inhibitor-combinations
#46
JOURNAL ARTICLE
Darren J Bentley
A two-dimensional "checkerboard" array employing systematic titration (e.g., serial two-fold dilutions) is a well-established in vitro method for exploring the antibacterial effects of novel drug combinations. Minimum inhibitory concentrations (MICs) on the checkerboard are isoeffective points at which the antibiotic potency is the same. Representations of checkerboard MIC curves for a β-lactam and β-lactamase inhibitor combination are used in hypothetical "thought experiments" and reveal the ways in which current practices can be improved...
April 7, 2024: Antibiotics
https://read.qxmd.com/read/38667000/age-related-differences-in-vancomycin-associated-nephrotoxicity-and-efficacy-in-methicillin-resistant-staphylococcus-aureus-infection-a-comparative-study-between-elderly-and-adult-patients
#47
JOURNAL ARTICLE
Lin Xi, Shanshan Li, Mengting Chen, Xiaolan Huang, Nanyang Li, Nanye Chen, Hailan Wu, Qiyu Bian, Xingchen Bian, Xin Li, Minjie Yang, Xiaoyu Liang, Jufang Wu, Beining Guo, Yaxin Fan, Jing Zhang
Elderly patients (age ≥ 65 years) are susceptible to methicillin-resistant Staphylococcus aureus (MRSA) infections, with potential for more adverse treatment outcomes or complications compared to younger adults (18-64 years). This study compared vancomycin-associated nephrotoxicity and efficacy in elderly and adult patients and investigated the correlation between vancomycin pharmacokinetic/pharmacodynamic (PK/PD) indices and clinical outcomes. A prospective study was conducted in 10 hospitals in Shanghai from October 2012 to November 2019...
April 3, 2024: Antibiotics
https://read.qxmd.com/read/38666972/comparative-impact-of-an-optimized-pk-pd-target-attainment-of-piperacillin-tazobactam-vs-meropenem-on-the-trend-over-time-of-sofa-score-and-inflammatory-biomarkers-in-critically-ill-patients-receiving-continuous-infusion-monotherapy-for-treating-documented
#48
JOURNAL ARTICLE
Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
(1) Background: The advantage of using carbapenems over beta-lactam/beta-lactamase inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed to assess the comparative impact of an optimized pharmacokinetic/pharmacodynamic (PK/PD) target attainment of piperacillin-tazobactam vs. meropenem on the trend over time of both Sequential Organ Failure Assessment (SOFA) score and inflammatory biomarkers in critically ill patients receiving continuous infusion (CI) monotherapy with piperacillin-tazobactam or meropenem for treating documented Gram-negative bloodstream infections (BSI) and/or ventilator-associated pneumonia (VAP)...
March 25, 2024: Antibiotics
https://read.qxmd.com/read/38666474/daptomycin-exposure-prediction-with-a-limited-sampling-strategy
#49
JOURNAL ARTICLE
Simona De Gregori, Elena Seminari, Mara Capone, Paola Giordani, Rsffaele Bruno, Annalisa De Silvestri
BACKGROUND: Daptomycin is a cyclic lipopeptide antibiotic used to treat serious infectious endocarditis caused by Staphylococcus aureus. The pharmacodynamic parameter correlating best with efficacy is the ratio of the estimated area under the concentration (AUC0-24)-time curve to the minimum inhibitory concentration. The aim of the study is to develop a limited sampling strategy to estimate AUC0-24 using a reduced number of samples. METHODS: Sixty-eight daptomycin AUC0-24 values were calculated for 50 White patients who underwent treatment for at least 5 consecutive days...
April 25, 2024: Therapeutic Drug Monitoring
https://read.qxmd.com/read/38666228/comparison-of-fat-free-mass-and-ideal-body-weight-scalar-for-anesthetic-induction-dose-of-propofol-in-patients-with-morbid-obesity-a-double-blind-randomized-clinical-trial
#50
JOURNAL ARTICLE
Soudabeh Djalalimotlagh, Mahmoud Reza Mohaghegh, Mohammad Reza Ghodraty, Amineh Shafeinia, Faranak Rokhtabnak, Tina Alinia, Farnoosh Tavakoli
BACKGROUND: Obesity is a growing problem worldwide and can affect both the pharmacodynamics and pharmacokinetics of various drugs, including anesthetics, resulting in the under-or overdosing of certain drugs. There is no consensus on the ideal dosing regimen for obese populations. OBJECTIVES: In this study, 2 weight-based dosing of propofol used for induction of anesthesia were compared in terms of the onset of action time, adequacy of anesthesia, and effects on hemodynamic indices (eg, heart rate [HR] and blood pressure)...
December 2023: Anesthesiology and Pain Medicine
https://read.qxmd.com/read/38666150/target-controlled-infusion-a-comparative-prospective-observational-study-of-the-conventional-tci-pump-and-the-novel-smartphone-based-application-itiva
#51
JOURNAL ARTICLE
Shagun B Shah, Rajiv Chawla, Manish Gupta
BACKGROUND AND AIMS: Empirically adjusted, standard drug doses fail to address interindividual pharmacokinetic and pharmacodynamics variability. Target-controlled infusion (TCI) delivers drugs in calibrated boluses to achieve and maintain a selected target plateau drug level (plasma or effect site). Interactive total intravenous anesthesia (iTIVA™ ) smartphone software simulates TCI and employs 31 established pharmacokinetic models for 11 different intravenous agents and is coupled with standard volumetric infusion pumps for administering TCI...
2024: Journal of Anaesthesiology, Clinical Pharmacology
https://read.qxmd.com/read/38666023/-in-vitro-pharmacokinetics-pharmacodynamics-of-fl058-a-novel-beta-lactamase-inhibitor-combined-with-meropenem-against-carbapenemase-producing-enterobacterales
#52
JOURNAL ARTICLE
Zhiwei Huang, Xingchen Bian, Yi Li, Jiali Hu, Beining Guo, Xinyi Yang, Yi Jin, Shansong Zheng, Xinmei Wang, Cong Gao, Jing Zhang, Xiaojie Wu
Objective: FL058 is a novel beta-lactamase inhibitor with a broad spectrum of activity and a favorable safety profile. The objective of this study was to evaluate pharmacokinetic/pharmacodynamic (PK/PD) relationships for the combination of FL058 and meropenem in an in vitro infection model. Methods: By simulating human concentration-time profiles in the in vitro model, meropenem combined with FL058 when administered 1 g/0.5 g, 1 g/1 g, 2 g/1 g, and 2 g/2 g q8h by 3-h infusion achieved approximately 2- and 4-log10 kill to KPC/OXA-producing Klebsiella pneumoniae and Escherichia coli ; the combination therapy could not inhibit NDM-producing K...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38665880/structure-based-virtual-screening-of-mangiferin-derivatives-with-antidiabetic-action-a-molecular-docking-and-dynamics-study-and-mpo-based-drug-likeness-approach
#53
JOURNAL ARTICLE
Francisco Flávio da Silva Lopes, Francisco Nithael Melo Lúcio, Matheus Nunes da Rocha, Victor Moreira de Oliveira, Caio Henrique Alexandre Roberto, Márcia Machado Marinho, Emmanuel Silva Marinho, Selene Maia de Morais
UNLABELLED: Extracts from Mangifera indica leaves and its main component, mangiferin, have proven antidiabetic activity. In this study, mangiferin and its natural derivatives Homomangiferin (HMF), Isomangiferin (IMF), Neomangiferin (NMF), Glucomangiferin (GMF), Mangiferin 6'-gallate (MFG), and Norathyriol (NRT) were compared regarding their action on Diabetes mellitus (DM), employing docking and molecular dynamics (MD) simulations to analyze interactions with the aldose reductase enzyme, the precursor to the conversion of glucose into sorbitol...
May 2024: 3 Biotech
https://read.qxmd.com/read/38665845/improving-olaparib-exposure-to-optimize-adverse-effects-management
#54
JOURNAL ARTICLE
Marylise Sterlé, Alicja Puszkiel, Chloé Burlot, Eva Pereira, Audrey Bellesoeur, Sixtine De Percin, Guillaume Beinse, Jean-David Fumet, Laure Favier, Julie Niogret, Benoit Blanchet, Bernard Royer, Leïla Bengrine-Lefevre, Antonin Schmitt
BACKGROUND: Olaparib is an inhibitor of the human poly-(ADP-ribose)-polymerase enzymes (PARP1/2) needed to repair single-strand DNA breaks. It is used in breast, ovarian, prostate and pancreatic cancer. OBJECTIVES: This work aimed to describe the pharmacokinetics/pharmacodynamics (PK/PD) relationship between olaparib plasma concentrations and common adverse effects (i.e. anaemia and hypercreatininaemia), in a real-life setting, to propose a target concentration for therapeutic drug monitoring...
2024: Therapeutic Advances in Medical Oncology
https://read.qxmd.com/read/38665218/abemaciclib-pharmacology-and-interactions-in-the-treatment-of-hr-her2-breast-cancer-a-critical-review
#55
REVIEW
Federica Martorana, Maria Vita Sanò, Maria Rosaria Valerio, Stefano Fogli, Paolo Vigneri, Romano Danesi, Vittorio Gebbia
Abemaciclib (ABE) in combination with endocrine therapy represents the mainstay treatment for either endocrine-resistant metastatic or high-risk early-stage HR+/HER2- breast cancer patients. Hence, an adequate knowledge of this agent pharmacodynamic, pharmacokinetic, and of its drug-drug interactions (DDIs) is crucial for an optimal patients management. Additionally, ABE interference with food and complementary/alternative medicines should be taken into account in the clinical practice. Several online tools allow to freely check DDIs and can be easily consulted before prescribing ABE...
2024: Therapeutic Advances in Drug Safety
https://read.qxmd.com/read/38665214/ich-s1-prospective-evaluation-study-weight-of-evidence-approach-to-predict-outcome-and-value-of-2-year-rat-carcinogenicity-studies-a-report-from-the-regulatory-authorities-subgroup
#56
JOURNAL ARTICLE
Todd Bourcier, Timothy McGovern, Tania Cavaliero, Geoffrey Ebere, Akiyoshi Nishikawa, Jihei Nishimura, Kumiko Ogawa, Markku Pasanen, Alisa Vespa, Jan Willem Van der Laan
Introduction: The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) initiated a process in 2012 to revise the S1B Guideline "Testing for Carcinogenicity of Pharmaceuticals". Previous retrospective analysis indicated the importance of histopathological risk factors in chronic toxicity studies, evidence of endocrine perturbation, and positive genetic toxicology results as potentially predictive indicators of carcinogenic risk. In addition, a relationship between pharmacodynamic activity and carcinogenicity outcome in long-term rodent studies has been reported...
2024: Frontiers in toxicology
https://read.qxmd.com/read/38664354/pbpk-modeling-to-predict-the-pharmacokinetics-of-venlafaxine-and-its-active-metabolite-in-different-cyp2d6-genotypes-and-drug-drug-interactions-with-clarithromycin-and-paroxetine
#57
JOURNAL ARTICLE
Chang-Keun Cho, Pureum Kang, Choon-Gon Jang, Seok-Yong Lee, Yun Jeong Lee, Jung-Woo Bae, Chang-Ik Choi
Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is indicated for the treatment of major depressive disorder, social anxiety disorder, generalized anxiety disorder, and panic disorder. Venlafaxine is metabolized to the active metabolite desvenlafaxine mainly by CYP2D6. Genetic polymorphism of CYP2D6 and coadministration with other medications can significantly affect the pharmacokinetics and/or pharmacodynamics of venlafaxine and its active metabolite. This study aimed to establish the PBPK models of venlafaxine and its active metabolite related to CYP2D6 genetic polymorphism and to predict drug-drug interactions (DDIs) with clarithromycin and paroxetine in different CYP2D6 genotypes...
April 25, 2024: Archives of Pharmacal Research
https://read.qxmd.com/read/38664069/study-on-the-active-components-and-mechanism-of-atractylodis-macrocephalae-rhizoma-for-invigorating-the-spleen-and-tonifying-qi-based-on-spectrum-effect-relationship-and-network-pharmacology
#58
JOURNAL ARTICLE
Yafei Li, Lulu Tang, Mingfang Zhao, Rui Tang, Keer Fang, Weihong Ge, Weifeng Du
Spleen deficiency can lead to various abnormal physiological functions of the spleen. Atractylodis Macrocephalae Rhizoma (AMR) is a traditional Chinese medicine used to invigorate the spleen and tonify qi. The study aimed to identify the primary active components influencing the efficacy of AMR in strengthening the spleen and replenishing qi through spectrum-effect relationship and chemometrics. Network pharmacology was used to investigate the mechanism by which AMR strengthens the spleen and replenishes qi, with molecular docking utilized for validation purposes...
April 25, 2024: Biomedical Chromatography: BMC
https://read.qxmd.com/read/38662798/lipid-gelucire-based-rectal-delivery-of-ramipril-prodrug-exhibits-significant-lowering-of-intra-ocular-pressure-in-normotensive-rabbit-sustained-structural-relaxation-release-kinetics-and-ivivc
#59
JOURNAL ARTICLE
Souvik Nandi, Rakesh Swain, Sk Habibullah, Rudra Narayan Sahoo, Amit Kumar Nayak, Subrata Mallick
Carboxylesterase enzymes convert a prodrug ramipril into the biologically active metabolite ramiprilat. It is prescribed for controlling ocular hypertension after oral administration. High concentrations of carboxylesterase enzymes in rectal and colon tissue can transform ramipril significantly to ramiprilat. Sustained rectal delivery of ramipril has been developed for intra-ocular pressure lowering effect using a normotensive rabbit model. Rectal suppositories have been formulated using a matrix base of HPMC K100-PEG 400-PEG 6000, incorporating varying amounts of Gelucire by the fusion moulding method...
April 25, 2024: Pharmaceutical Development and Technology
https://read.qxmd.com/read/38662339/the-pharmacist-s-role-in-optimizing-medication-management-before-during-and-after-minimally-invasive-and-bariatric-surgery
#60
JOURNAL ARTICLE
Laura M Ebbitt, Lynn E Kassel, Jeffrey J McKenzie, Nicole M Palm, April N Smith
DISCLAIMER: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: Minimally invasive surgery (MIS) with integrated enhanced recovery pathways (ERPs) helps reduce length of stay and improve surgical outcomes...
April 25, 2024: American Journal of Health-system Pharmacy: AJHP
keyword
keyword
6597
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.